Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02157025
Other study ID # KID_VF
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 2015
Est. completion date December 2024

Study information

Verified date July 2023
Source Nova Southeastern University
Contact Katherine E Green, OD
Phone 954-262-4227
Email kgreen2@nova.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The majority of young children do not think that visual field (VF) testing of peripheral vision is similar to a game; therefore, it is not surprising that they have difficulty maintaining attention during VF testing and thus the test reliability suffers as a consequence. Poor VF reliability has been a longstanding, major issue since it leads to an increased number of tests and/or longer duration of time needed to determine when there are true vision losses. Providers are less likely to obtain VF tests in children since the results are of doubtful value and challenging to interpret when they are inconsistent. Effectively this means that children with untreated, slowly progressive eye diseases may go undiagnosed and incur greater visual losses. The investigators aim to create a prototype device that the investigators hypothesize will make VF testing more engaging for young children, thus increasing their attention and consistency of their responses to the test stimuli, which in turn should improve VF reliability. The components include a microdisplay video screen (1.5" diameter) as the fixation target (instead of the standard LED light) displaying video clips of popular cartoon characters, and audio clips of impersonated cartoon character voices presented by the test operator to provide instructional feedback based on the child's performance during testing. Improved VF reliability from the investigators intervention would translate to improved diagnosis and care for young childrens' peripheral vision loss through widespread implementation of the investigators innovative, affordable and readily adoptable system at eye care providers' offices.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date December 2024
Est. primary completion date April 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 5 Years to 8 Years
Eligibility Inclusion Criteria: - Ages 5-8 - Seen previously in the clinics at Nova Southeastern University's The Eye Care Institute with a diagnosis for glaucoma suspect or optic nerve abnormalities - Able and willing to complete VF testing at 2 study visits about a week apart - Provide informed consent Exclusion Criteria: - History of having previously completed a VF test using Humphrey static perimetry - Inability to understand study or communicate responses (cognitive impairment) - Unable to understand, read and speak English fluently

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Cartoon video fixation target and cartoon character voice audio instructions during Humphrey perimetry

Other:
Usual Care procedures during Humphrey perimetry for children


Locations

Country Name City State
United States The Eye Care Institute Fort Lauderdale Florida

Sponsors (1)

Lead Sponsor Collaborator
Nova Southeastern University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Humphrey Visual Field Test-Retest Variability of Mean Deviation scores (dB) Within subject, the investigators will determine the coefficient of variation in the mean deviation scores obtained at the two sessions a week apart (dB). The investigators will test for significant differences between subjects who receive the intervention versus the usual care control group for the test-retest variability. 1 week
Secondary Humphrey Visual Field Reliability Indices and Ratings The investigators will test for significant differences between subjects who receive the intervention versus the usual care control group for the visual field reliability criteria (false negatives, false positives and fixation losses; expressed as %), and operator ratings (subjects' fixation, cooperation and fatigue; scale 1 to 5). 1 week
See also
  Status Clinical Trial Phase
Recruiting NCT05235321 - Automated Applanation Tonometry N/A
Completed NCT04972695 - Validation of an Automatic Analysis Algorithm of the Probability of Glaucoma From Optic Disc Images
Completed NCT03534882 - Effects of Prostaglandin Analogue Washout Following Long-term Therapy in Adults With Primary Open Angle Glaucoma N/A
Active, not recruiting NCT02394613 - A Phase I Clinical Trial of DARC Phase 1
Completed NCT05686421 - Comfortable and Stabilizing Chin & Forehead Rest Attachment for Slit Lamp Configurations N/A
Completed NCT03978546 - Diagnostic Performance of Smart Supra Perimetry (The DPSSP Study) N/A
Recruiting NCT05850936 - Effect of IOP Lowering on Progressive HM N/A
Recruiting NCT06388096 - CLAD Deconvolved PERG Responses in Glaucoma Patients N/A
Recruiting NCT03972852 - Establishment of an Anaesthetic Protocol for Examinations for Children With Glaucoma or Suspected Glaucoma
Terminated NCT04454190 - Development and Validation of a Model to Predict Fast Progression in Glaucoma
Terminated NCT04639947 - Reliability and Reproducibility of the Eye Check Tonometer N/A
Recruiting NCT05670015 - Ocular Changes With Alpha-2 Receptor Agonist. N/A
Recruiting NCT05279716 - Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl Phase 4
Recruiting NCT05352906 - Accuracy of Handheld and Non-contact Tonometry N/A
Recruiting NCT04296916 - Effect of Lowering IOP in Glaucoma Suspects With HM N/A